drugset / Trial / NCT01628731

Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease

NCT01628731

Phase 3 Completed 74 enrolled Bambino Gesù Hospital and Research Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to verify if ethacrynic acid continuous infusion is superior to furosemide continuous infusion in total urine output production during the first 24 post operative hours.

Timeline

Start
2012-10
Primary completion
2013-07
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Furosemide Other / unclassified 0.2 mg/kg Intravenous
Comparator ethacrynic acid Small molecule 0.2 mg/kg Intravenous

Indications

No indication recorded.